GRINX | VSMPX | GRINX / VSMPX | |
Total Expense Ratio | 1.36 | 0.02 | 6,800% |
Annual Report Gross Expense Ratio | 1.36 | 0.02 | 6,800% |
Fund Existence | 26 years | 10 years | - |
Gain YTD | 2.214 | 0.837 | 264% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 325M | 1.82T | 0% |
Annual Yield % from dividends | 0.00 | 1.29 | - |
Returns for 1 year | 2.31 | 10.97 | 21% |
Returns for 3 years | 9.11 | 40.40 | 23% |
Returns for 5 years | 30.88 | 81.02 | 38% |
Returns for 10 years | 6.43 | 171.64 | 4% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 28.77 | N/A | N/A |
Fidelity Advisor Biotechnology I | |||
FEYIX | 27.80 | N/A | N/A |
Fidelity Advisor Asset Manager 85% I | |||
MNHRX | 25.79 | N/A | N/A |
Manning & Napier Pro-Blend Max Term R | |||
FWMNX | 17.06 | N/A | N/A |
Fidelity Advisor Women's Leadership I | |||
EEMHX | 8.78 | N/A | N/A |
MFS Emerging Markets Equity Research R6 |